Showing results (21-30 of 3,777) with videos related to
Sort By:
Pageof 378
Clinical Nuclear Medicine|January 1, 1993
Study of the tumor marker carbohydrate antigen 50 in liver cirrhosis. Pathogenetic considerationsJ Collazos, J Genolla, A RuibalClinical Chemistry|April 1, 1991
Neuron-specific enolase concentrations in serum in benign liver diseasesJ Collazos, J Genollá, A RuibalClinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1992
CA 19-9 in non-neoplastic liver diseases. A clinical and laboratory studyJ Collazos, J Genolla, A RuibalThe International Journal of Biological Markers|April 1, 1992
Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluationJ Collazos, J Genolla, A RuibalScandinavian Journal of Clinical and Laboratory Investigation|October 1, 1993
A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disordersJ Collazos, J Genollá, A RuibalAIDS Patient Care and Stds|May 22, 2001
Fever of unknown origin in the setting of HIV infection: guidelines for a rational approachJ Mayo, J Collazos, E MartinezMedicine|November 27, 1999
Hypersensitivity reactions to rifampin. Pathogenetic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactionsE Martínez, J Collazos, J MayoScandinavian Journal of Infectious Diseases|October 31, 2000
Thrombotic microangiopathy as a cause of dilated cardiomyopathy in HIV-infected patientsJ Mayo, J Collazos, E MartínezThe American Journal of Gastroenterology|March 1, 1993
Serum levels of CA 50 in nonmalignant liver diseases: a clinical and biochemical studyJ Collazos, J Genolla, A RuibalThe International Journal of Biological Markers|October 1, 1992
Tissue polypeptide antigen (TPA) in chronic active hepatitis and mild liver diseasesJ Collazos, J Genollà, A RuibalPageof 378